Evidence map›Paper›PMID 30589478›Full record

ArticleAddiction (Abingdon, England)2019

Response to FDA Commissioner's statement on Dsuvia approval.

Michael H Bernstein, Francesca L Beaudoin, Molly Magill

Registry-linked trialAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Addiction (Abingdon, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04263909 (The Impact of Sublingual Sufentanil on Postoperative Pain and Analgesic), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04263909 phase4completednot on this mapstarted 2020, after this paper: background citation

The Impact of Sublingual Sufentanil on Postoperative Pain and Analgesic

TypeinterventionalSponsorBrigham and Women's HospitalRan2020 to 2023Enrolled199ConditionsSpine Fusion, Pain, Postoperative, Opioid UseArmsSublingual Tablet
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Michael H BernsteinSchool of Public Health, Center for Alcohol and Addiction Studies, Brown University, Providence, RI, USA.ORCID 0000-0001-7221-0697
Francesca L BeaudoinDepartment of Emergency Medicine, Alpert Medical School of Brown University, Providence, RI, USA.
Molly MagillSchool of Public Health, Center for Alcohol and Addiction Studies, Brown University, Providence, RI, USA.

Funding

Substance Abuse Intervention/Outcome Research TrainingT32DA016184 · NIDA · BROWN UNIVERSITY · PI Damaris J. Rohsenow, JENNIFER W. TIDEY · 2003 to 2026
$6.1M
NIDA NIH HHS T32 DA016184NIDA NIH HHS T32DA016184
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Dissent and DisputesDrug ApprovalAnalgesics, OpioidBiasClinical Studies as TopicConfounding Factors, EpidemiologicHumansSufentanilUnited StatesAnalgesics, OpioidDsuviaSufentanilDsuviamedicationopioidopioid crisisprescription opioidSufentanil

Identifiers

PMID30589478
PMCPMC6411435

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.